Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity - primarily organ transplant recipients who take immunosuppressive medications to reduce the risk of ...

The adjusted incident rate ratio (IRR) for GBS post-RSV disease was 2.11, reflecting a slightly more than double risk. The ...

Dr. Stephania Cormier discovered she had asthma in her early 20s. Her discovery of a respiratory illness catapulted Cormier's work in respiratory illness and research. Cormier is now a professor and ...

Scanning electron micrograph of human respiratory syncytial virus (RSV) virions (colorized blue) and tagged with antibodies (colorized yellow) against the virus’ fusion protein — the target of RSV ...

Immune responses to respiratory syncytial virus (RSV) vaccines tended to fall short in older people with weakened immunity, a study found. In 38 immunocompromised persons who received either the ...

RSV, which stands for r espiratory syncytial virus, is surgi ng in number of cases and hospitalizations in young patients across the country. RSV can cause severe clinical problems in infants, ...

A new phase 1 randomized controlled trial finds that a single dose of the ChAdox1 Rift Valley fever (RVF) vaccine appears ...

If you miss the October vaccination window, there is still plenty of time to get protected before Thanksgiving. With Thanksgiving on Nov. 27 this year, you have until Nov. 13 to get your shots and be ...

Moderna said Wednesday that its experimental mRNA-based seasonal flu vaccine generated a stronger immune response against four strains of the flu virus than a currently marketed vaccine in a Phase 3 ...